AGILENT TECHNOLOGIES, INC. is 10.0x more valuable than 10x Genomics, Inc. by market capitalization ($37.20 B vs $3.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TXG | A |
|---|---|---|
| Market cap | $3.72 B | $37.20 B |
| US-listed rank | #1634 | #403 |
| Revenue (latest FY) | $642.82M | $6.95B |
| Net income (latest FY) | -$43.50M | $1.30B |
| Net margin | -6.8% | 18.8% |
| P/E (trailing FY) | - | 28.5 |
| SEC filings | 652 | 2,339 |
AGILENT TECHNOLOGIES, INC. is 10.0x more valuable than 10x Genomics, Inc. by market capitalization ($37.20 B vs $3.72 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: 10x Genomics, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.